Daily Hong Kong Stock Market News Briefing (December 12, Thursday)
Individual Stock News
-
Xiaocai Garden: Plans to globally issue approximately 101 million shares, expected to be listed on December 20.
-
Haitian Flavor Industry: Plans to issue H shares and apply for listing on the main board of the Hong Kong Stock Exchange.
-
New Oriental (09901.HK): Dr. Yang Zhuang has resigned from the position of independent director of the company, effective from December 16, 2024.
-
SINO BIOPHARM (01177.HK): Methanesulfonic acid elobixibat injection has received market approval from the National Medical Products Administration of China for the treatment of locally advanced or metastatic breast cancer patients who have previously received at least two chemotherapy regimens (including anthracyclines and taxanes).
-
AIA Group (01299.HK): The company spent approximately HKD 62.73 million to repurchase about 1.07 million shares, accounting for 0.0098% of the issued shares.
-
BOSS Zhipin (02076.HK): Total revenue for the third quarter was approximately RMB 1.912 billion, a year-on-year increase of 19%; net profit attributable to ordinary shareholders of the company was approximately RMB 468 million, compared to approximately RMB 426 million in the same period last year.
-
Beike (02423.HK): Entered into a cloud service and technology service framework agreement with Tencent.
-
Beijing Automotive (01958.HK): BAIC Investment and Hyundai Motor proportionally injected USD 1.095 billion into Beijing Hyundai.
-
China Pacific Insurance (02601.HK): Pacific Life Insurance's premium income from January to November was RMB 228.842 billion, a year-on-year increase of 2.2%.
-
China General Nuclear Power Corporation New Energy (01811.HK): Completed power generation of 1,360.8 GWh in November, a year-on-year decrease of 18%